The Moxibustion-Induced Thermal Transport Effect Between The Heart And Lung Meridians

NCT ID: NCT05330403

Last Updated: 2022-04-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

80 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-04-30

Study Completion Date

2021-12-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Although some important progresses were made in the field of the meridian research, no breakthroughs have been achieved. Besides,there are some problems in meridian researches. Particularly, previous research of meridian phenomenon involved lots of subjective elements and outcomes. Researches that use modern scientific techniques to investigate the biological characteristics of meridian phenomenon are urgently needed. Therefore, this study was designed to assess the heat transport characteristics of meridian phenomenon for the Heart and Lung meridians by using infrared thermography. Thus, the biological characteristics of meridian phenomenon could be presented objectively in a scientific methodology.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

80 eligible subjects were finally included. Among them, 40 participants were assigned to the lung meridian intervention group, and 40 participants were assigned to the heart meridian intervention group. All 80 participants completed the trial.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Meridians

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

the lung meridian intervention group

moxibustion intervention was performed over Site 1 (LU5) of the lung meridian

Group Type EXPERIMENTAL

Moxibustion

Intervention Type PROCEDURE

In this study, suspended moxibustion was performed by holding an ignited moxa stick at a certain distance (about 3-4 cm) over the skin surface, keeping the moxibustion Site warm without burning the skin.

In the heart meridian intervention group, moxibustion was applied over Site 4 (HT3) of the heart meridian.

In the lung meridian intervention group, moxibustion was performed over Site 1 (LU5) of the lung meridian.

the heart meridian intervention group

moxibustion intervention was applied over Site 4 (HT3) of the heart meridian

Group Type EXPERIMENTAL

Moxibustion

Intervention Type PROCEDURE

In this study, suspended moxibustion was performed by holding an ignited moxa stick at a certain distance (about 3-4 cm) over the skin surface, keeping the moxibustion Site warm without burning the skin.

In the heart meridian intervention group, moxibustion was applied over Site 4 (HT3) of the heart meridian.

In the lung meridian intervention group, moxibustion was performed over Site 1 (LU5) of the lung meridian.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Moxibustion

In this study, suspended moxibustion was performed by holding an ignited moxa stick at a certain distance (about 3-4 cm) over the skin surface, keeping the moxibustion Site warm without burning the skin.

In the heart meridian intervention group, moxibustion was applied over Site 4 (HT3) of the heart meridian.

In the lung meridian intervention group, moxibustion was performed over Site 1 (LU5) of the lung meridian.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Had recent medical examination records confirming the absence of cardiovascular, respiratory, digestive, urinary, hematological, endocrine and neurological diseases
* 20 ≤ age ≤ 40 years, male or female
* Had the ability to communicate with others normally
* An understanding of the entire study protocol
* Signed written informed consent

Exclusion Criteria

* Had mental illnesses, severe depression, alcohol dependence or a history of drug abuse
* Pregnant or lactating
* Were participating in other trials
Minimum Eligible Age

20 Years

Maximum Eligible Age

40 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

The Third Affiliated hospital of Zhejiang Chinese Medical University

OTHER

Sponsor Role collaborator

Zhejiang Chinese Medical University

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Jianqiao Fang

President

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jianqiao Fang, Ph.D

Role: PRINCIPAL_INVESTIGATOR

Zhejiang Chinese Medical University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

the Third affiliated hospital of Zhejiang Chinese Medical university

Hanzhou, Zhejiang, China

Site Status

Countries

Review the countries where the study has at least one active or historical site.

China

References

Explore related publications, articles, or registry entries linked to this study.

Li X, Jiang Y, Hu H, Lou J, Zhang Y, He X, Wu Y, Fang J, Shao X, Fang J. The Moxibustion-Induced Thermal Transport Effect Between the Heart and Lung Meridians With Infrared Thermography. Front Cardiovasc Med. 2022 May 13;9:817901. doi: 10.3389/fcvm.2022.817901. eCollection 2022.

Reference Type DERIVED
PMID: 35647050 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2019ZY010-MERIDIAN

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Moxibustion for Primary Dysmenorrhea
NCT01972906 COMPLETED EARLY_PHASE1
Acute Health Effects of High Temperature Exposure
NCT05575752 ACTIVE_NOT_RECRUITING NA